At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued rapid growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarized this month’s top Irish Life Science industry news stories below.
200 jobs promised for Tipperary as Rockshel Life Sciences invest in Cashel
200 jobs are being promised by Rockshel Life Sciences in Cashel, Co. Tipperary. Following the closure of the Sun Pharma/Ranbaxy plant in 2016, Cashel suffered a loss of 100 jobs. Rockshel are now set to reboot the town’s Life Science sector by investing €14m in a former pharmaceutical plant, with much of the product to be exported to the US and Canada. Click here to read the full article.
Edwards Lifesciences to invest €80m in the Mid-West and create 600 jobs
The global leader in patient-focused innovations for structural heart disease and critical care monitoring, Edwards Lifesciences, has chosen the Mid-West of Ireland for the location of a new plant to manufacture delivery components for its transcatheter heart valve therapies. This investment is totaling €80m and will create up to 600 jobs. The company plans to complete this new, purpose-built manufacturing facility in 2020. And the opportunity does not stop there, as Edwards is also planning to hire approximately 60 people this year to work at its initial site located in the Shannon Free Zone. Click here to read the full article.
Takeda to invest €25m in new regenerative medicine operation at Grange Castle site
Takeda is to create up to 70 new jobs and invest €25m in the construction of a new regenerative medicine facility at its site in Grange Castle. This is the second announcement in two years from Takeda, as the company previously announced a €40m investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio also in Grange Castle. Click here to read the full article.
MSD announce development of a new Biotech facility at former Swords site, creating up to 350 new jobs
The rapidly growing MSD is set to construct a new Biotechnology facility, which will be known as MSD Biotech, Dublin. This facility will be built on an existing MSD-owned property in Swords and will create up to 350 jobs. The new biotech unit will be manufacturing the cancer drug ‘Keytruda’ and is planned to be fully operational & certified by 2022. This announcement is a follow on from last year when MSD announced that they will be hiring 330 new staff in Cork and Carlow in a €280m investment. Click here to read the full article.
Emerson & NIBRT collaborate to upskill the Biopharma Workforce in Ireland
Following a 2016 NIBRT study of the Biopharma manufacturing industry that found more than half of respondents have a high degree of difficulty recruiting and developing Bioprocess engineers, Emerson have collaborated with the National Institute of Bioprocessing Research and Training to help train next-generation workers on the latest technologies designed to optimize pharmaceutical production. Emerson is providing automation software and systems valued at $1m to NIBRT for this initiative. The planned Emerson Room at the NIBRT facility will simulate an innovative Bioprocessing environment and feature a fully operational DeltaV system to provide real-life training in a safe environment. Click here to read the full article.
LSC host Robotics Workshops and sponsor new STEM education programme
As part of LSC’s commitment to promoting STEM as a subject and career choice we kicked off Engineers week by holding Robotics workshops in Kinsale open to children of our consultants and all in the community. Engineer’s week also brought us to the launch of the Summercove National school STEM education programme. We are delighted to sponsor this long-term Robotics initiative, where 4th class pupils will work weekly with Lego education Robotics and continue to gain skills and insight into the world of STEM. Click here to read the full article.